Table 4.
Author | Modality | Subgroup | LV‐EDD | LA Size (Diameter/Volume) | LVEDMI | LV‐EDVI | LV‐ESVI | LVRI | Comment |
---|---|---|---|---|---|---|---|---|---|
Bukkam8 | CT | 0.42a , b | On multivariable regression adjusted for traditional cardiovascular risk factors, CACS and BMI, EAT was not a significant predictor of LV mass in obese patients, but only in nonobese patients (β=0.23, P<0.001) | ||||||
Cavalcante9 | Echocardiography | 0.41a | Measure not included in multivariate analysis | ||||||
Al Chekakie7 | CT and echocardiography | 0.25/0.24 | |||||||
Doesch11 | MRI |
EF <50% (n=44) EF >50% (n=114) Combined (n=158) |
0.076 0.011 0.272a |
0.336a
0.305a 0.019 |
0.201a
0.043 0.16a |
0.089 0.056 0.262a |
0.137 0.202 0.344a |
On multivariable regression including LVEF, BMI, NYHA classes I and III, atrial fibrillation, LV‐EDVI, LV‐ESVI, LV‐EFF, LVRI, and LGE%, best correlates to indexed EAT were LVEF, BMI, LV‐ESVI (HR, 0.48; P<0.01), and LV‐EDD (HR, −0.238; P=0.01). In subgroup analysis by EF <50% or >50%, full model not described; however, no association with LVEDMI in LVEF >50% but association seen in LVEF >50% (HR, 0.105; P=0.01) | |
Doesch12 | MRI |
Control (n=48) DCM (n=112) |
0.01 0.22a |
0.346a
0.417a |
0.007 0.251a |
0.0001 0.239a |
0.204 0.116 |
Increased EAT mass with increasing LVEDMI in DCM, but less values than healthy control group. Greater mass seen in DCM with hypertrophy vs nonhypertrophy (31.7±5.6 vs 24.4±7.1 g/m2; P=0.01). On multivariable regression only, LVEDMI independently correlated with indexed EAT, as was seen in healthy controls (adjusted for age and BMI [value not reported]). | |
Doesch10 | MRI |
Control CHF |
NR 0.42a |
0.36a
0.59a |
Increased EAT mass in CHF with increasing LVEDMI; however, higher levels of EAT in controls compared with CHF (34±4 vs 22±5 g/m2; P<0.01). On multivariate regression adjusted for LVEF, LV‐EDD, RVEF, and LVEDMI, only LVEDMI independently associated with indexed EAT (P=0.0001) | ||||
Fox17 | MRI |
Women Men |
0.28a
0.37a |
0.35a
,
c
0.19a , c |
0.2a
,
c
0.07c |
On multivariable regression adjusted for age, height, smoking, alcohol, menopause, hormone replacement therapy, blood pressure, hypertension therapy, and weight, only in women, LVM (adjusted regression coefficient, 1.66; P=0.01), and in men, LA diameter (adjusted regression coefficient, 0.8; P=0.002) were independent predictors of pericardial fat volume | |||
Hachiya18 | Echocardiography | 0.28a | Measure not included in multivariate analysis | ||||||
Konishi20 | Echocardiography | 0.32a | 0.23a | Measure not included in multivariate analysis | |||||
Liu22 | Echocardiography |
Women Men |
0.3a
0.11 |
0.24a
,
c
0.21a , c |
On multivariable regression adjusted for age, height, smoking, alcohol, blood pressure, eGFR, hemoglobin, total physical activity score, medications, VAT, and weight, only in women, LVM (adjusted regression coefficient, 4.1±1.8; P=0.03) and LA diameter (adjusted regression coefficient, 0.4±0.2; P=0.03) were independent predictors of pericardial fat volume | ||||
Ng24 | Echocardiography | −0.09 | 0.08 | ||||||
Ruberg3 | MRI | Not | |||||||
Vanni25, d | MRI | Cases | 0.46a , e |
Inversely correlated with EF No other analysis specified |
|||||
Yamashita28, d | CT | 0.25a |
Values are mean±SD or r value correlation coefficients, unless otherwise stated. BMI indicates body mass index; CACS, coronary artery calcium score; CHF, congestive heart failure; CT, computed tomography; DCM, dilated cardiomyopathy; EAT, epicardial adipose tissue; EF, ejection fraction; eGFR, estimated glomerular filtration rate; HR, hazard ratio; LA, left atrial; LGE%, percentage of late gadolinium enhancement; LV, left ventricular; LV‐EDVI, LV end‐diastolic volume index; LV‐EDD, LV end‐diastolic diameter; LVEF, LV ejection fraction; LVEDMI, LV end‐diastolic mass index; LV‐EDVI, LV end‐diastolic volume index; LV‐ESVI, LV end‐systolic volume index; LVRI, LV remodeling index; MRI, magnetic resonance imaging; NR, not reported; NYHA, New York Heart Association; RVEF, right ventricular EF; VAT, visceral adipose tissue.
P < 0.05.
Value is for LV mass on CT, nonindexed and time in cardiac cycle not specified.
Represents a nonindexed measure.
Study is a conference abstract.
Value is for end‐systolic LV diameter.